| Acne |
No |
| Active Half-Life |
5-7 days |
| Active substance |
Tamoxifen Citrate |
| Also known as |
Tamoxifen |
| Aromatization |
No |
| Blood pressure |
Generally does not affect blood pressure |
| Chemical name |
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine |
| Classification |
SERM |
| Dosage |
20-40 mg/day |
| Dosage (medical) |
20 mg per day |
| Dosage (sports) |
10-20 mg per day |
| Effects |
Reduces estrogen binding to receptors, prevents gynecomastia, promotes a more favorable hormone balance for testosterone |
| Formula |
C26H29NO |
| Half-life |
5 to 7 days |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Blood estrogen levels |
| Main action |
Antiestrogen |
| Side effects |
Hot flashes, vaginal dryness or discharge, mood swings, nausea, headache |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Estrogen Receptor Modulator (SERM) |
| Trade name |
Nolvadex |
| Use in sports |
Used to combat gynecomastia and improve the testosterone to estrogen ratio |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
AstraZeneca |
